The focus: what you need to know about the silent illness
Hepatitis is an inflammatory disease of the liver that affects millions of people worldwide. World Hepatitis Day is observed annuallyonJuly 28 to raise awareness of this often asymptomatic but potentially life-threatening disease. This day of action was established by the World Health Organization (WHO) in 2010. The date commemorates the birthday of Dr. Baruch Blumberg, who discovered the hepatitis B virus and was awarded the Nobel Prize for his work. This day aims to highlight the importance of early detection, prevention, and treatment of hepatitis and to unite efforts to reduce the number of hepatitis-related deaths worldwide.
What is hepatitis?
Hepatitis refers to inflammation of the liver, which can be triggered by various causes. However, the disease is most commonly caused by viral infections, with the five main types of hepatitis viruses—A, B, C, D, and E—being the most significant. These viruses differ in their modes of transmission, prevalence, and health impacts.

How many people have hepatitis?
Hepatitis in Germany
In Germany, the prevalence rates for hepatitis B and C are relatively low compared to other parts of the world, but still significant. The prevalence of hepatitis B is 0.3–0.7% of the population. Given a population of approximately 83 million people, this means that about 250,000 to 580,000 people in Germany are chronically infected with hepatitis B. About 0.2–0.3% are affected by hepatitis C. This corresponds to approximately 160,000 to 250,000 people in Germany who are infected with hepatitis C. Hepatitis A and E are less common in Germany and often occur in the form of outbreaks, which are generally attributable to travel to countries with higher prevalence rates. Exact figures vary depending on the year and the occurrence of outbreaks.
Hepatitis in European and Non-European Countries
In Europe, prevalence rates vary greatly between countries. Countries such as Italy, Romania, and Bulgaria have higher prevalence rates for hepatitis B and C compared to Germany. In Southern Europe, rates are generally higher, which can be attributed to factors such as differences in healthcare infrastructure, vaccination rates, and health education. Globally, prevalence rates are significantly higher in Africa and Asia. In some African countries, the prevalence of hepatitis B exceeds 8%, while in Southeast Asia, the prevalence of hepatitis C can exceed 3%. These high rates are often due to a combination of limited access to health care, lower vaccination rates, and higher transmission rates resulting from unsafe medical practices.
What are the liver’s functions?
Metabolism and Energy Storage
| Function | Description |
|---|---|
| Glucose Metabolism | The liver regulates blood sugar levels by storing glucose (in the form of glycogen) and releasing it as needed. |
| Lipid metabolism | The liver produces cholesterol and triglycerides, which are necessary for the formation of cell membranes and energy production. It also plays a role in the processing of dietary fats. |
| Protein metabolism | In the liver, proteins such as It synthesizes albumin and clotting factors, which are essential for maintaining blood volume and blood clotting. |
Detoxification and excretion
| Function | Description |
|---|---|
| Breakdown of toxins | The liver filters harmful substances out of the blood, including alcohol, medications, and environmental toxins. These are converted into less harmful substances or excreted via bile. |
| Ammonia breakdown | The liver converts ammonia, a byproduct of protein metabolism, into urea, which is then excreted by the kidneys. |
Bile Production
| Function | Description |
|---|---|
| Bile secretion | The liver produces bile, which is stored in the gallbladder and released into the small intestine as needed. Bile is important for the emulsification and digestion of fats. |
Storage function
| Function | Description |
|---|---|
| Storage of Vitamins and Minerals | The liver stores fat-soluble vitamins (A, D, E, and K) as well as the water-soluble vitamin B12 and important minerals such as iron and copper. |
Synthesis of Blood Proteins
| Function | Description |
|---|---|
| Albumin production | Albumin is the most abundant protein in blood plasma and is important for the transport of hormones, vitamins, and medications, as well as for maintaining colloid osmotic pressure, which keeps water in the bloodstream. |
| Coagulation factors | The liver produces several proteins that are essential for blood clotting, including fibrinogen and prothrombin. |
Immune function
| Function | Description |
|---|---|
| Defense against pathogens | The liver contains many immune cells, particularly Kupffer cells, which remove and break down bacteria and foreign substances from the blood. |
Regulation of hormone balance
| Function | Description |
|---|---|
| Hormone metabolism | The liver is involved in the regulation of hormones by breaking down and inactivating excess hormones. These include sex hormones, thyroid hormones, and corticosteroids. |
Causes of Hepatitis
Hepatitis can be caused by various factors that lead to inflammation of the liver. The most common causes are:

- Viral Infections: Viral infections are the primary cause of hepatitis worldwide. Hepatitis viruses A, B, C, D, and E are the main causes, with each virus having different modes of transmission, prevalence rates, and health effects.
- Toxins: Certain substances, such as alcohol, certain medications, and industrial chemicals, can damage the liver and cause toxic hepatitis.
- Autoimmune diseases: In autoimmune hepatitis, the immune system mistakenly attacks liver cells, which can lead to chronic inflammation.
- Nonalcoholic fatty liver disease (NAFLD): This form of hepatitis is common in people who are overweight, have diabetes, or have metabolic syndrome, and it leads to a buildup of fat in the liver, which causes inflammation.
- Genetic disorders: Some genetic conditions, such as hemochromatosis or Wilson’s disease, can lead to excessive storage of iron or copper in the liver, which can result in inflammation and liver damage.

How is hepatitis diagnosed?
Medical history
The diagnosis of hepatitis is a complex process that involves various testing methods to identify the exact type of hepatitis, determine the severity of the disease, and develop appropriate treatment strategies. The diagnostic process typically begins with a thorough medical history, during which risk factors such as recent travel, sexual contacts, drug use, and previous medical procedures are assessed. This is followed by specific laboratory tests, which play a central role in the diagnosis of hepatitis.
Serological Tests
These are often the first step in blood testing using abutterfly needle. These tests look for antibodies or antigens that indicate infection with hepatitis viruses. For example, if hepatitis A is suspected, testing is performed for anti-HAV IgM antibodies, which indicate an acute infection. For hepatitis B, several serological markers are tested, including the hepatitis B surface antigen (HBsAg), which indicates an acute or chronic infection, as well as anti-HBs, which indicates immunity following a resolved infection or vaccination. For hepatitis C, an antibody test (anti-HCV) is usually performed first. If this test is positive, an HCV RNA test is conducted to confirm an active infection and determine the viral load.
Molecular biological tests
In particular, the polymerase chain reaction (PCR) is crucial for detecting the genetic material of the viruses and quantifying the viral load. These tests are especially important in the diagnosis and monitoring of hepatitis B and C, as they help determine active viral replication and monitor response to antiviral therapy.
Imaging Techniques
In addition to laboratory tests, imaging
techniques
play an important role in assessing liver health. A liver ultrasound is a non-invasive method for detecting changes in liver structure, such as enlargement or signs of cirrhosis. Elastography (e.g., FibroScan) measures the Liver elasticity and helps determine the extent of scarring. In certain cases—particularly when test results are inconclusive or to accurately assess the severity of liver damage—a liver biopsy may be performed. During this procedure, a small tissue sample is taken and examined under a microscope to precisely determine the degree of inflammation and fibrosis.Follow-up Care
After the initial diagnosis, regular follow-up is crucial. This includes repeated blood tests to monitor liver enzyme levels, bilirubin levels, and viral load in order to assess the course of the disease and the response to treatment. Repeated imaging studies, such as ultrasound or elastography, may be necessary to continuously monitor liver health and respond early to complications.

What complications can arise from hepatitis?
Hepatitis, particularly in its chronic forms, can have serious health consequences and complications. These primarily affect the liver but can also impact other organ systems. The following lists the most important consequences and complications of hepatitis:
| Complication | Description |
|---|---|
| Cirrhosis | A progressive disease in which healthy liver tissue is replaced by scar tissue, impairing liver function. Often caused by chronic hepatitis B, C, and D. |
| Liver Cancer (HCC) | Hepatocellular carcinoma, a form of liver cancer that often occurs in association with chronic hepatitis B and C. Increased risk due to chronic inflammation and cirrhosis. |
| Liver failure | A condition in which the liver can no longer perform its functions. It can be acute or chronic. |
| Hepatic encephalopathy | A neurological disorder caused by the liver’s inability to break down toxic substances such as ammonia. Symptoms range from drowsiness to a comatose state. |
| Portal hypertension | Elevated blood pressure in the portal vein, often resulting from cirrhosis of the liver, can lead to varicose veins (varices) in the esophagus and stomach, which are life-threatening. |
| Ascites | Fluid accumulation in the abdominal cavity, which is frequently associated with liver cirrhosis and portal hypertension. It can lead to infections and breathing difficulties. |
| Hepatorenal syndrome | A serious complication in which kidney function is severely impaired, often as a result of advanced liver disease. Requires immediate medical treatment. |
| Coagulopathy | A disorder of blood clotting due to reduced production of clotting factors in the damaged liver. Increased risk of bleeding. |
| Increased susceptibility to infection | Increased risk of bacterial infections due to weakened immune function, particularly in cirrhosis of the liver (e.g., spontaneous bacterial peritonitis). |
| Osteoporosis | Bone loss that can be caused by chronic liver diseases such as hepatitis. Increased risk of bone fractures. |
| Depression and Anxiety | Psychological stress caused by chronic liver disease, which can lead to depression and anxiety. |
| Glomerulonephritis | An inflammatory disease of the kidneys that can occur particularly in cases of hepatitis B and C. It leads to impaired kidney function and protein loss in the urine. |
Hepatitis, particularly in its chronic forms, can cause a variety of serious complications affecting the liver and other organ systems. Timely diagnosis and treatment of hepatitis are crucial to reducing the risk of such complications. Regular monitoring, preventive measures, and early intervention can help slow the progression of the disease and improve the quality of life for those affected.

How can you prevent hepatitis?
Preventing hepatitis is crucial to stopping the spread of this potentially serious liver disease and protecting public health. Prevention measures vary depending on the type of hepatitis virus and include vaccinations, hygiene practices, education, and safe behaviors. The following lists the most important prevention strategies for hepatitis:
Vaccination
-
Hepatitis A: A vaccine against hepatitis A is available and is particularly recommended for travelers to countries with high prevalence, people with chronic liver disease, and individuals in occupations with a high risk of exposure. The vaccine consists of two doses administered 6 to 12 months apart and provides long-term protection.
-
Hepatitis B: The hepatitis B vaccine is one of the most effective preventive measures and is routinely recommended for all infants as well as for high-risk individuals, including healthcare workers, people who inject drugs, and those with multiple sexual partners. The vaccine is typically administered in three doses over a six-month period and provides long-term protection.
-
Hepatitis C, D, and E: There are currently no vaccines against hepatitis C and D. Prevention therefore focuses on behavioral changes and minimizing the risk of transmission. A vaccine against hepatitis E is available in some countries for certain at-risk groups, such as pregnant women in high-risk areas.
Safe injection and transfusion practices
-
Avoiding shared needles: Since hepatitis B, C, and D can be transmitted through blood, it is crucial to avoid sharing needles and syringes. This applies particularly to intravenous drug users, but also in medical settings.
-
Safe Blood Transfusions: In countries with high standards, blood products are routinely tested for hepatitis viruses. Nevertheless, it is important to ensure that blood transfusions are performed only in qualified medical facilities to minimize the risk of transmission.
Protection During Sexual Contact
- Use of condoms: Since hepatitis B can be transmitted through sexual activity, the use of condoms reduces the risk of infection. This is particularly important for people with multiple sexual partners or in regions with high hepatitis B prevalence.
Hygiene measures
- Hygienic Food and Water Handling: To avoid hepatitis A and E, travelers to high-risk areas should drink only boiled or bottled water, avoid raw or undercooked foods, and pay attention to hygiene when preparing meals.
- Wash your hands: Regular handwashing, especially after using the restroom and before eating, is a simple yet effective measure to prevent the transmission of hepatitis A and E. Remember that regularhand sanitizingspecifically kills pathogens and can therefore further limit transmission routes.
Education and behavioral change
-
Education programs: Awareness campaigns in schools, communities, and health centers can increase awareness of the risks of hepatitis and the importance of preventive measures. This includes information on safe sexual practices, the dangers of drug abuse, and the importance of vaccinations.
-
Reducing Drug Abuse: Programs aimed at reducing drug use, particularly intravenous drug use, can help reduce the spread of hepatitis B, C, and D. This can be achieved through education, support for withdrawal, and access to clean needles and syringes.
Regular testing and screenings
-
Screening of at-risk groups: People in at-risk groups, such as drug users, healthcare workers, pregnant women, and individuals with multiple sexual partners, should be tested regularly for hepatitis to enable early diagnosis and treatment.
-
Early detection: Regular checkups and early testing can help detect hepatitis infections at an early stage and prevent the spread of the disease.
Hepatitis prevention is a multifaceted approach that includes vaccinations, safe behavioral practices, hygiene measures, and education. By combining these strategies, the risk of hepatitis infection can be significantly reduced. Adherence to these preventive measures is particularly important in regions with high hepatitis prevalence and for individuals at increased risk of infection.
Who are the right people to contact and where should you go for help?
If a person is diagnosed with hepatitis or suspects they may be infected, it is important to contact specialized centers, experts, and clinics to receive the best possible care and treatment. Here are the most important resources for people with hepatitis in Germany:
Family doctor or general practitioner
- First point of contact: The family doctor is usually the first person to contact if hepatitis is suspected. They can conduct an initial examination, order blood tests, and, if necessary, refer the patient to a specialist.
- Treatment and monitoring: For mild or uncomplicated cases, the family doctor can provide treatment and regular monitoring.
Specialists in Gastroenterology and Hepatology
- Specialists in liver diseases: Gastroenterologists and hepatologists specialize in diseases of the digestive system and the liver. They perform detailed diagnoses, monitor the course of the disease, and initiate specialized treatments.
- Long-Term Care: Patients with chronic hepatitis are often cared for over the long term by a gastroenterologist or hepatologist to monitor the progression of the disease and prevent complications.
Liver centers and specialized clinics
- Specialized care: In major cities, there are specialized liver centers and clinics that focus on the diagnosis and treatment of liver diseases, including hepatitis. These centers offer state-of-the-art diagnostic procedures and treatment options.
- Multidisciplinary Teams: Liver centers often work with a team of specialists, including hepatologists, surgeons, oncologists, and nutritionists, to ensure comprehensive care.
Self-Help Groups and Patient Organizations
- Deutsche Leberhilfe e.V.: One of the most important self-help organizations in Germany, offering information, support, and networking opportunities for people with liver diseases, including hepatitis. They organize regular meetings, informational events, and offer Telephone counseling.
- Internet forums and online communities: There are several online platforms where those affected can exchange ideas and support one another. These forums offer an opportunity to share experiences and receive emotional support.
Public health departments
- Counseling and education: Public health departments offer educational programs, information on prevention, and vaccination options. They can also assist in finding medical specialists or specialized clinics.
- Vaccinations and Preventive Measures: Many public health departments offer free or low-cost vaccinations against hepatitis A and B, especially for people in high-risk groups.
Public Health Organizations
- World Health Organization (WHO): The WHO provides comprehensive information and global guidelines on hepatitis prevention, diagnosis, and treatment. It supports campaigns worldwide to reduce hepatitis-related deaths.
- Robert Koch Institute (RKI): In Germany, the RKI provides important epidemiological data and information on hepatitis. It offers guidelines for the management of hepatitis infections and promotes preventive measures.
Hospitals and Emergency Rooms
- Acute Care: In emergencies—especially in cases of severe symptoms such as jaundice, extreme fatigue, or acute complications—affected individuals should go to a hospital or emergency room immediately to receive prompt medical care.
- Inpatient Treatment: In cases of severe disease progression or complications such as liver cirrhosis or liver cancer, hospitalization may be necessary.
There are numerous resources in Germany that offer comprehensive support to people with hepatitis. From the initial diagnosis through specialized treatment to social and emotional support, various institutions and specialists are available to help those affected cope with the disease and improve their quality of life. It is important to seek medical help early on and to contact the appropriate specialists and organizations as needed.

